G

Galmed Pharmaceuticals Ltd
D

GLMD

1.37000
USD
-0.04
(-2.84%)
مغلق
حجم التداول
1,658
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,093,507
أصول ذات صلة
A
ALKS
-0.700
(-2.33%)
29.340 USD
A
ARDX
0.02000
(0.51%)
3.97500 USD
C
CRIS
-0.01000
(-0.51%)
1.97000 USD
I
IMAB
-0.01000
(-0.94%)
1.05000 USD
L
LXRX
-0.00820
(-1.24%)
0.65140 USD
R
RGNX
-0.13000
(-1.32%)
9.73000 USD
S
SRRK
-0.510
(-1.67%)
30.000 USD
V
VYGR
-0.05500
(-1.85%)
2.91500 USD
المزيد
الأخبار المقالات

العنوان: Galmed Pharmaceuticals Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.